Patent Application Approval Granted to Eastar Chemical for Novel Prostaglandin Technology

Share Article

Eastar Chemical Corporation, a US-based producer of fine and specialty chemicals with manufacturing plants in China and a unique on time, on-spec guarantee, recently celebrated a new milestone in its 25+ year history. With the filing of a key patent application covering a novel and more efficient route to the glaucoma drug Latanoprost and other prostaglandin intermediates, Eastar Chemical has firmly established itself as a strong player in the prostaglandine field and is showing its commitment to grow as an advanced technology company.

Eastar Chemical Corporation, a US-based producer of fine and specialty chemicals with manufacturing plants in China and a unique on time, on-spec guarantee, recently celebrated a new milestone in its 25+ year history. With the filing of a key patent application covering a novel and more efficient route to the glaucoma drug Latanoprost and other prostaglandin intermediates, Eastar Chemical has firmly established itself as a strong player in the prostaglandine field and is showing its commitment to grow as an advanced technology company.

"There is significant interest in Latanoprost and this has become a very competitive segment of the pharma API industry," notes Michel Bulliard, Vice President of Pharma Products. "Our process provides a very efficient and cost effective route to these key therapeutic compounds. It also clearly demonstrates our technical capabilities and positions ourselves as leaders in this market segment."

Since its founding as a trading company more than 25 years ago, Eastar has evolved into a full-fledged custom manufacturer and supplier of fine and specialty chemicals with a wide range of technical capabilities, including chiral chemistry, selective hydrogenations, hazardous chemistry (phosgene, cyanide), phosphorous chemistry and much more. The company strives to identify the most efficient routes to products it manufactures and has the technical capability to develop novel synthetic pathways and unique new molecules.

The patented prostaglandin chemistry was developed in partnership with Professor Jiang Xing Chen of the Shanghai Institute of Planned Parenthood Research (SIPPS). "We want to become recognized as a leader in the development of innovative technologies," notes President Tony Chu. Collaborating with highly-respected university researchers is just one way we are working to achieve that goal."

The recently granted patent also underscores Eastar's commitment to finding the best possible solutions for its customers. Along with its advanced chemical technologies, Eastar has developed an extensive project management system, created a highly skilled QA/QC team, established global logistics expertise and implemented effective intellectual property protection programs. The company has access to an extensive yet secure supply chain and offers its customers an on time, on-spec guarantee.

"There are many different suppliers of fine and specialty chemicals in China. But none can offer the combination of technical expertise, investment in innovation and commitment to quality and customer satisfaction that defines Eastar," said Bulliard.

To find out more about the different prostaglandins and prostaglandin intermediates offered by Eastar, visit: http://www.eastarchem.com.

About Eastar Chemical Corporation
A California based company, Eastar Chemical Corporation is a custom / toll manufacturer offering both process development and chemical manufacturing services to the pharmaceutical, electronic, veterinary, agrochemical, specialty polymers, and other fine and specialty chemical industries. With over 20 years of manufacturing experience in China, Eastar has fine tuned its own and partner production capabilities to provide a wide range of high quality, reliable, manufacturing and development services with an awareness of and focus on the maintenance of confidentiality and intellectual property rights. Eastar is committed to the principles of ChemStewards/Responsible Care® and is a long standing member of SOCMA and DCAT.

Media Contact: Thor Harris
On behalf of Eastar Chemical Corporation
Phone : +1 201-206-0903
e-mail: thor (at) percepture (dot) com

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

THOR HARRIS
Eastar
+1 201-206-0903
Email >
Visit website